Hologic (HOLX) Announces Favorable Ruling in SenoRx Patent Infringement Suit
Hologic (Nasdaq: HOLX) shares are trading just off session highs as the company announced a favorable ruling in its patent infringement suit related to SenoRx.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Lilly & Co. (LLY) Ticks Lower After Filing 10-Q
- Valeant Pharma (VRX) Names Former OSC Commissioner Kavanagh as Director
- Alere (ALR) Affirms Receipt of DOJ Subpoena; Issues Commentary
Create E-mail Alert Related CategoriesLitigation, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!